Significant Behavioral Recovery in Parkinson's Disease Model by Direct Intracerebral Gene Transfer Using Continuous Injection of a Plasmid DNA–Liposome Complex-Reference-Cited by-同舟云学术

Significant Behavioral Recovery in Parkinson's Disease Model by Direct Intracerebral Gene Transfer Using Continuous Injection of a Plasmid DNA–Liposome Complex

Published:1998-05 Issue:7 Volume:9 Page:1093-1102
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Imaoka Takashi,Date Isao,Ohmoto Takashi,Nagatsu Toshiharu

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1998.9.7-1093

Reference32 articles.

1. Double Transduction with GTP Cyclohydrolase I and Tyrosine Hydroxylase Is Necessary for Spontaneous Synthesis ofl-DOPA by Primary Fibroblasts

2. Gene Therapy of Parkinson Disease Model Rat by Direct Injection of Plasmid DNA–Lipofectin Complex

3. Isolation and expression of rat liver sepiapterin reductase cDNA.

4. Long-Term Behavioral Recovery in Parkinsonian Rats by an HSV Vector Expressing Tyrosine Hydroxylase

5. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy for Neurological Disorders Using Nanomaterial-Based Drug Delivery Vehicle;Smart Nanomaterials Technology;2024

2. Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview;Journal of Neural Transmission;2023-08-28

3. Gene Therapy for Parkinson’s Disease, An Update;Journal of Parkinson's Disease;2018-06-13

4. Personalized nanomedicine for CNS diseases;Drug Discovery Today;2018-05

5. Nanotechnology in Neuroscience and its Perspective as Gene Carrier;Current Topics in Medicinal Chemistry;2017-03-27